These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 201940)

  • 41. The effect of dopamine-beta-hydroxylase inhibitors, dimethylphenylthiourea and fusaric acid, on locomotor and exploratory activity, body temperature, and regional distribution of biogenic amines in the rat brain.
    Vetulani J; Reichenberg K; wiszniowska G; Marchaj J
    Pol J Pharmacol Pharm; 1973; 25(6):559-72. PubMed ID: 4792476
    [No Abstract]   [Full Text] [Related]  

  • 42. Dopamine-beta-hydroxylase: a modulator of beta adrenergic receptor activity.
    Thomas JA; Sakai KK; Holck MI; Marks BH
    Res Commun Chem Pathol Pharmacol; 1980 Jul; 29(1):3-13. PubMed ID: 6250208
    [TBL] [Abstract][Full Text] [Related]  

  • 43. The psychological effects of dopamine-beta-hydroxylase inhibition in normal subjects.
    Hartmann E; Keller-Teschke M
    Biol Psychiatry; 1979 Jun; 14(3):455-62. PubMed ID: 476231
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Distribution of catecholamine-synthesizing enzymes in goldfish brains: presumptive dopamine and norepinephrine neuronal organization.
    Hornby PJ; Piekut DT
    Brain Behav Evol; 1990; 35(1):49-64. PubMed ID: 1971189
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Thyrotropin-releasing hormone in the pancreas and brain of the rat is regulated by central noradrenergic and dopaminergic pathways.
    Engler D; Chad D; Jackson IM
    J Clin Invest; 1982 Jun; 69(6):1310-20. PubMed ID: 6806317
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Studies on memory: the cerebral spread of an engram in mice as affected by inhibitors of dopamine beta-hydroxylase.
    Flexner JB; Flexner LB; Church AC
    Pharmacol Biochem Behav; 1983 Apr; 18(4):519-23. PubMed ID: 6867057
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Diurnal rhythm in the central dopamine turnover in the rat.
    Lemmer B; Berger T
    Naunyn Schmiedebergs Arch Pharmacol; 1978 Jul; 303(3):257-61. PubMed ID: 567283
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Pharmacological action of FD-008, a new dopamine-beta-hydroxylase inhibitor. III. Effects on endogenous biogenic amine levels in rats.
    Ishii Y; Homma M; Yoshikawa A; Umezawa H
    Arzneimittelforschung; 1975 Mar; 25(3):383-5. PubMed ID: 1174036
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Motility response to morphine and amphetamine during chronic inhibition of tyrosine hydroxylase or dopamine beta-hydroxylase.
    Khalsa JH; Davis WM
    J Pharmacol Exp Ther; 1977 Jul; 202(1):182-91. PubMed ID: 17725
    [No Abstract]   [Full Text] [Related]  

  • 50. Effect of dopamine-beta-hydroxylase inhibition on cerebral vasospasm in the cat.
    Battista AF; Flamm ES; Goldstein M; Freedman LS
    J Neurosurg; 1976 Feb; 44(2):168-72. PubMed ID: 1245859
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Effect of FLA-63, p-chlorophenylalanine and pimozide on the metabolism and incorporation of 3H-thymidine in the brain of rat pups.
    Béndek G
    Prog Neuropsychopharmacol Biol Psychiatry; 1983; 7(2-3):203-10. PubMed ID: 6225149
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Effect of a dopamine beta-hydroxylase inhibitor on tissue catecholamine levels in spontaneously hypertensive rats subjected to immobilization-cold stress.
    Ishi Y; Homma M; Yoshikawa A
    Neuropharmacology; 1975 Feb; 14(2):155-7. PubMed ID: 1153081
    [No Abstract]   [Full Text] [Related]  

  • 53. Role of brain norepinephrine in neuroleptic-induced catalepsy in rats.
    Honma T; Fukushima H
    Pharmacol Biochem Behav; 1977 Dec; 7(6):501-6. PubMed ID: 201939
    [No Abstract]   [Full Text] [Related]  

  • 54. The use of neurotoxins to characterize the rates and subcellular distributions of axonally transported dopamine-beta-hydroxylase, tyrosine hydroxylase and norepinephrine in the rat brain.
    Levin BE
    Brain Res; 1979 May; 168(2):331-50. PubMed ID: 87244
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Effect of an inhibitor of dopamin-beta-hydroxylase on the acquistion and retention of four different avoidance tasks in mice.
    Izquierdo I; Beamish DG; Anisman H
    Psychopharmacology (Berl); 1979 May; 63(2):173-8. PubMed ID: 112636
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Analysis of brain adrenergic receptors in dopamine-beta-hydroxylase knockout mice.
    Sanders JD; Szot P; Weinshenker D; Happe HK; Bylund DB; Murrin LC
    Brain Res; 2006 Sep; 1109(1):45-53. PubMed ID: 16854392
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Norepinephrine-dopamine interactions and behavior.
    Antelman SM; Caggiula AR
    Science; 1977 Feb; 195(4279):646-53. PubMed ID: 841304
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Inhibition of LH and prolactin release in the cycling rat following inhibition of dopamine-beta-hydroxylase.
    Voogt JL; Carr LA
    Brain Res; 1981 Mar; 209(2):411-9. PubMed ID: 6112041
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Effects of dopamine beta-hydroxylase genotype and disulfiram inhibition on catecholamine homeostasis in mice.
    Bourdélat-Parks BN; Anderson GM; Donaldson ZR; Weiss JM; Bonsall RW; Emery MS; Liles LC; Weinshenker D
    Psychopharmacology (Berl); 2005 Nov; 183(1):72-80. PubMed ID: 16163519
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Influence of dopamine-beta-hydroxylase inhibition on the cardiovascular and respiratory actions of dopamine in rats.
    Riancho JA; del Arco C; Pazos A; Flórez J
    Rev Esp Fisiol; 1982 Dec; 38(4):461-9. PubMed ID: 7170431
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.